Search results
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 3 weeks agoShares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report,...
3 Things You Need to Know If You Buy Novavax Today
Motley Fool via Yahoo Finance· 1 week agoNovavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 2 weeks agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 6 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Could Novavax Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Investor's Business Daily· 2 years agoNovavax could struggle to find a U.S. market for its Covid vaccine, according to the latest IBD/TIPP...